Leiden University Scholarly Publications

Beta release

Statistics of Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma
Statistics for this year
PeriodVisitsDownloads
20248973
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0999
2024-101211
2024-1133